Identifying small molecules for protecting chondrocyte function and matrix integrity after controlled compressive...

Area of Science:

• Biomedical Engineering
• Orthopedics
• Pharmacology

Background:

• Articular cartilage injury is a primary driver of post-traumatic osteoarthritis (PTOA).
• Current therapies for osteoarthritis (OA) have limited success in halting disease progression.
• Early intervention following cartilage damage is crucial to prevent irreversible tissue deterioration.

Purpose of the Study:

• To develop and validate a high-throughput screening platform for identifying novel chondroprotective compounds.
• To discover small molecules that mitigate biological responses to articular cartilage injury.
• To advance therapeutic strategies for preventing PTOA.

Main Methods:

• A multi-platen system was engineered to simultaneously impact 48 cartilage tissue analogs (CTAs).
• Over 500 small molecules were screened for their effects on matrix degradation and chondrocyte stress.
• Secondary screening assessed 55 compounds, identifying 16 candidates with chondroprotective potential.

Main Results:

• The screening platform successfully identified compounds that reduce proteoglycan loss and matrix metalloproteinase activity.
• Sixteen promising compounds demonstrated activity in protecting chondrocyte function following impact injury.
• Identified compounds include natural products, redox agents, stem cell-related compounds, and various enzyme inhibitors.

Conclusions:

• The validated screening platform effectively models PTOA and identifies potential therapeutic agents.
• The identified compounds offer potential for early-stage protective therapy against PTOA.
• This platform represents a valuable tool for discovering novel molecules targeting early chondrocyte responses to injury.